These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38757212)
1. Intratumoral metabolic heterogeneity by Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212 [TBL] [Abstract][Full Text] [Related]
2. Intra-tumor metabolic heterogeneity of gastric cancer on Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779 [TBL] [Abstract][Full Text] [Related]
3. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors. Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782 [No Abstract] [Full Text] [Related]
4. Establishment and validation of a nomogram with intratumoral heterogeneity derived from Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465 [TBL] [Abstract][Full Text] [Related]
5. The Role of [ Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307 [No Abstract] [Full Text] [Related]
6. Diagnostic and prognostic values of 2-[ Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559 [TBL] [Abstract][Full Text] [Related]
9. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139 [TBL] [Abstract][Full Text] [Related]
10. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters. Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
12. Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer. Liu S; Feng Z; Jiang Z; Wen H; Xu J; Pan H; Deng Y; Zhang L; Ju X; Chen X; Wu X Nucl Med Commun; 2018 Oct; 39(10):928-935. PubMed ID: 29771717 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity index evaluated by slope of linear regression on Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1995-2003. PubMed ID: 28634684 [TBL] [Abstract][Full Text] [Related]
14. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor. Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment quantitative Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]